Elecsys HCV Duo shows high agreement in multicenter hepatitis C evaluation
A three-hospital Chinese study found 96.97% agreement between Elecsys HCV Duo and a two-assay comparator workflow, with earlier antigen detection ...
A three-hospital Chinese study found 96.97% agreement between Elecsys HCV Duo and a two-assay comparator workflow, with earlier antigen detection ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.